|
1
|
Hackett ML and Pickles K: Part I:
Frequency of depression after stroke: An updated systematic review
and meta-analysis of observational studies. Int J Stroke.
9:1017–1025. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Campbell Burton CA, Murray J, Holmes J,
Astin F, Greenwood D and Knapp P: Frequency of anxiety after
stroke: A systematic review and meta-analysis of observational
studies. Int J Stroke. 8:545–559. 2013. View Article : Google Scholar
|
|
3
|
Barker-Collo SL: Depression and anxiety 3
months post stroke: Prevalence and correlates. Arch Clin
Neuropsychol. 22:519–531. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morrison V, Pollard B, Johnston M and
MacWalter R: Anxiety and depression 3 years following stroke:
Demographic, clinical, and psychological predictors. J Psychosom
Res. 59:209–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ayerbe L, Ayis S, Wolfe CD and Rudd AG:
Natural history, predictors and outcomes of depression after
stroke: Systematic review and meta-analysis. Br J Psychiatry.
202:14–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boden-Albala B, Litwak E, Elkind MS,
Rundek T and Sacco RL: Social isolation and outcomes post stroke.
Neurology. 64:1888–1892. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Whyte EM, Mulsant BH, Vanderbilt J, Dodge
HH and Ganguli M: Depression after stroke: A prospective
epidemiological study. J Am Geriatr Soc. 52:774–778. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ouimet MA, Primeau F and Cole MG:
Psychosocial risk factors in poststroke depression: A systematic
review. Can J Psychiatry. 46:819–828. 2001. View Article : Google Scholar
|
|
9
|
Meng C, Zhang JC, Shi RL, Zhang SH and
Yuan SY: Inhibition of interleukin-6 abolishes the promoting
effects of pair housing on post-stroke neurogenesis. Neuroscience.
307:160–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O’Keefe LM, Doran SJ, Mwilambwe-Tshilobo
L, Conti LH, Venna VR and McCullough LD: Social isolation after
stroke leads to depressive-like behavior and decreased BDNF levels
in mice. Behav Brain Res. 260:162–170. 2014. View Article : Google Scholar
|
|
11
|
Ebrahim S, Barer D and Nouri F: Use of the
nottingham health profile with patients after a stroke. J Epidemiol
Community Health. 40:166–169. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rasmussen A, Lunde M, Poulsen DL, Sorensen
K, Qvitzau S and Bech P: A double-blind, placebo-controlled study
of sertraline in the prevention of depression in stroke patients.
Psychosomatics. 44:216–221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Niedermaier N, Bohrer E, Schulte K,
Schlattmann P and Heuser I: Prevention and treatment of poststroke
depression with mirtazapine in patients with acute stroke. J Clin
Psychiatry. 65:1619–1623. 2004. View Article : Google Scholar
|
|
14
|
Robinson RG, Jorge RE, Moser DJ, Acion L,
Solodkin A, Small SL, Fonzetti P, Hegel M and Arndt S: Escitalopram
and problem-solving therapy for prevention of poststroke
depression: A randomized controlled trial. JAMA. 299:2391–2400.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Narushima K, Paradiso S, Moser DJ, Jorge R
and Robinson RG: Effect of antidepressant therapy on executive
function after stroke. Br J Psychiatry. 190:260–265. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Acler M, Robol E, Fiaschi A and Manganotti
P: A double blind placebo RCT to investigate the effects of
serotonergic modulation on brain excitability and motor recovery in
stroke patients. J Neurol. 256:1152–1158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jorge RE, Acion L, Moser D, Adams HJ Jr
and Robinson RG: Escitalopram and enhancement of cognitive recovery
following stroke. Arch Gen Psychiatry. 67:187–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cervo L, Rozio M, Ekalle-Soppo CB, Guiso
G, Morazzoni P and Caccia S: Role of hyperforin in the
antidepressant-like activity of Hypericum perforatum extracts.
Psychopharmacology (Berl). 164:423–428. 2002. View Article : Google Scholar
|
|
19
|
Chatterjee S, Filippov V, Lishko P,
Maximyuk O, Noldner M and Krishtal O: Hyperforin attenuates various
ionic conductance mechanisms in the isolated hippocampal neurons of
rat. Life Sci. 65:2395–2405. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Yao C, Chen J, Zhang Y, Yuan S
and Lin Y: Hyperforin promotes post-stroke functional recovery
through interleukin (IL)-17A-mediated angiogenesis. Brain Res.
1646:504–513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shetty AK: Hippocampal injury-induced
cognitive and mood dysfunction, altered neurogenesis, and epilepsy:
Can early neural stem cell grafting intervention provide
protection. Epilepsy Behav. 38:117–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Musil R, Schwarz MJ, Riedel M, Dehning S,
Cerovecki A, Spellmann I, Arolt V and Muller N: Elevated macrophage
migration inhibitory factor and decreased transforming growth
factor-beta levels in major depression-no influence of celecoxib
treatment. J Affect Disord. 134:217–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sutcigil L, Oktenli C, Musabak U, Bozkurt
A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N,
Ozsahin A and Sengul A: Pro- and anti-inflammatory cytokine balance
in major depression: Effect of sertraline therapy. Clin Dev
Immunol. 2007.76396:2007.
|
|
24
|
Turner CA, Thompson RC, Bunney WE,
Schatzberg AF, Barchas JD, Myers RM, Akil H and Watson SJ: Altered
choroid plexus gene expression in major depressive disorder. Front
Hum Neurosci. 8:2382014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee KM and Kim YK: The role of IL-12 and
TGF-beta1 in the pathophysiology of major depressive disorder. Int
Immunopharmacol. 6:1298–1304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krieglstein K, Zheng F, Unsicker K and
Alzheimer C: More than being protective: Functional roles for
TGF-β/activin signaling pathways at central synapses. Trends
Neurosci. 34:421–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Mao X, Zhou T, Cheng X and Lin Y:
IL-17A contributes to brain ischemia reperfusion injury through
calpain-TRPC6 pathway in mice. Neuroscience. 274:419–428. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu J, Wu DM, Zheng YL, Hu B, Cheng W,
Zhang ZF and Shan Q: Ursolic acid improves high fat diet-induced
cognitive impairments by blocking endoplasmic reticulum stress and
IκB kinase β/nuclear factor-κB-mediated inflammatory pathways in
mice. Brain Behav Immun. 25:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma M, Ma Y, Yi X, Guo R, Zhu W, Fan X, Xu
G, Frey WH II and Liu X: Intranasal delivery of transforming growth
factor-beta1 in mice after stroke reduces infarct volume and
increases neurogenesis in the subventricular zone. BMC Neurosci.
9:1172008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Hinojosa R, Haun J, Hinojosa MS and
Rittman M: Social isolation poststroke: Relationship between
race/ethnicity, depression, and functional independence. Top Stroke
Rehabil. 18:79–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Steptoe A, Shankar A, Demakakos P and
Wardle J: Social isolation, loneliness, and all-cause mortality in
older men and women. Proc Natl Acad Sci USA. 110:5797–5801. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morris PL, Robinson RG and Raphael B:
Prevalence and course of depressive disorders in hospitalized
stroke patients. Int J Psychiatry Med. 20:349–364. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Venna VR, Weston G, Benashski SE,
Tarabishy S, Liu F, Li J, Conti LH and McCullough LD: NF-κB
contributes to the detrimental effects of social isolation after
experimental stroke. Acta Neuropathol. 124:425–438. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moraga A, Pradillo JM, Cuartero MI,
Hernandez-Jimenez M, Oses M, Moro MA and Lizasoain I: Toll-like
receptor 4 modulates cell migration and cortical neurogenesis after
focal cerebral ischemia. FASEB J. 28:4710–4718. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gross CG: Neurogenesis in the adult brain:
Death of adogma. Nat Rev Neurosci. 1:67–73. 2000. View Article : Google Scholar
|
|
37
|
Wang SH, Zhang ZJ, Guo YJ, Teng GJ and
Chen BA: Hippocampal neurogenesis and behavioural studies on adult
ischemic rat response to chronic mild stress. Behav Brain Res.
189:9–16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Loubinoux I, Kronenberg G, Endres M,
Schumann-Bard P, Freret T, Filipkowski RK, Kaczmarek L and
Popa-Wagner A: Post-stroke depression: Mechanisms, translation and
therapy. J Cell Mol Med. 16:1961–1969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jeong YJ, Kim WC, Kim YS, Choi KW, Son SY
and Jeong YG: The relationship between rehabilitation and changes
in depression in stroke patients. J Phys Ther Sci. 26:1263–1266.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mpembi MN, Miezi SM, Nzuzi TM, Massamba
VK, Henrard S, De Partz MP, Peeters A, Macq J, Dubois V and
Constant E: Clinical profile of post-cerebrovascular depression:
Descriptive cross-sectional study in the rehabilitation center for
people with disabilities of kinshasa (DR Congo). Pan Afr Med J.
17:1092014.In French.
|
|
41
|
Lin Y, Zhang JC, Fu J, Chen F, Wang J, Wu
ZL and Yuan SY: Hyperforin attenuates brain damage induced by
transient middle cerebral artery occlusion (MCAO) in rats via
inhibition of TRPC6 channels degradation. J Cereb Blood Flow Metab.
33:253–262. 2013. View Article : Google Scholar :
|
|
42
|
Chapman CD, Frey WH II, Craft S, Danielyan
L, Hallschmid M, Schioth HB and Benedict C: Intranasal treatment of
central nervous system dysfunction in humans. Pharm Res.
30:2475–2484. 2013. View Article : Google Scholar :
|
|
43
|
Illum L: Transport of drugs from the nasal
cavity to the central nervous system. Eur J Pharm Sci. 11:1–18.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pardridge WM: Drug targeting to the brain.
Pharm Res. 24:1733–1744. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Abbott NJ: Blood-brain barrier structure
and function and the challenges for CNS drug delivery. J Inherit
Metab Dis. 36:437–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dhuria SV, Hanson LR and Frey WH II:
Intranasal delivery to the central nervous system: Mechanisms and
experimental considerations. J Pharm Sci. 99:1654–1673. 2010.
View Article : Google Scholar
|
